Larimar Therapeutics
LRMR
#8139
Rank
A$0.49 B
Marketcap
A$4.74
Share price
-2.48%
Change (1 day)
-13.94%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): A-$2.89

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.95. In 2025 the company made an earnings per share (EPS) of A-$3.34 a decrease over its 2024 EPS that were of A-$1.96.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.89-13.31%
2025A-$3.3470%
2024A-$1.96
2022A-$2.33-48.15%
2021A-$4.49-14.27%
2020A-$5.23